1. Home
  2. SEAT vs IMA Comparison

SEAT vs IMA Comparison

Compare SEAT & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEAT
  • IMA
  • Stock Information
  • Founded
  • SEAT 2001
  • IMA 2019
  • Country
  • SEAT United States
  • IMA United States
  • Employees
  • SEAT N/A
  • IMA N/A
  • Industry
  • SEAT Industrial Machinery/Components
  • IMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SEAT Industrials
  • IMA Health Care
  • Exchange
  • SEAT Nasdaq
  • IMA Nasdaq
  • Market Cap
  • SEAT 96.5M
  • IMA 92.2M
  • IPO Year
  • SEAT N/A
  • IMA N/A
  • Fundamental
  • Price
  • SEAT $13.29
  • IMA $8.33
  • Analyst Decision
  • SEAT Buy
  • IMA
  • Analyst Count
  • SEAT 9
  • IMA 0
  • Target Price
  • SEAT $52.00
  • IMA N/A
  • AVG Volume (30 Days)
  • SEAT 111.0K
  • IMA 87.8K
  • Earning Date
  • SEAT 11-06-2025
  • IMA 11-15-2025
  • Dividend Yield
  • SEAT N/A
  • IMA N/A
  • EPS Growth
  • SEAT N/A
  • IMA N/A
  • EPS
  • SEAT N/A
  • IMA N/A
  • Revenue
  • SEAT $694,007,000.00
  • IMA $4,300,000.00
  • Revenue This Year
  • SEAT N/A
  • IMA N/A
  • Revenue Next Year
  • SEAT N/A
  • IMA N/A
  • P/E Ratio
  • SEAT N/A
  • IMA N/A
  • Revenue Growth
  • SEAT N/A
  • IMA N/A
  • 52 Week Low
  • SEAT $13.50
  • IMA $7.57
  • 52 Week High
  • SEAT $100.00
  • IMA $23.28
  • Technical
  • Relative Strength Index (RSI)
  • SEAT 38.55
  • IMA N/A
  • Support Level
  • SEAT $14.66
  • IMA N/A
  • Resistance Level
  • SEAT $15.45
  • IMA N/A
  • Average True Range (ATR)
  • SEAT 1.00
  • IMA 0.00
  • MACD
  • SEAT -0.46
  • IMA 0.00
  • Stochastic Oscillator
  • SEAT 6.72
  • IMA 0.00

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

About IMA ImageneBio Inc. Common Stock

ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.

Share on Social Networks: